ARCHIVES

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989

Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission

January 23, 1981

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012